Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Addressing Mental Health: A conversation with Barry Greene, CEO of Sage Therapeutics

By Stephen J. Ubl  |    May 30, 2023
As we recognize Mental Health Awareness Month, I had the opportunity to connect with PhRMA board member Barry Greene, CEO of Sage Therapeutics, about the company’s efforts to address mental health.     Read More

New calculator demonstrates how improved adherence to anti-diabetic medicines can benefit people in Medicaid

By Reid Porter  |    May 25, 2023
Diabetes is a scary diagnosis for anyone. When people with the disease struggle to manage their blood sugar levels, they can experience significant, life-threatening and costly complications such as...   Read More

Biopharmaceutical manufacturing companies continue to expand their economic footprint across the United States

By Tim McClung  |    May 24, 2023
Before 2020, the importance of robust and resilient supply chains and how they can affect access to life-saving treatments probably wasn’t top of mind for many outside the biopharmaceutical industry....   Read More

Setting the record straight on accelerated approval

By Andrew Powaleny  |    May 22, 2023
As we’ve discussed on this blog before, the U.S. Food and Drug Administration’s (FDA) accelerated approval program has served as a critical lifeline for patients with serious and life-threatening...   Read More

Four ways that America’s biopharmaceutical industry supports jobs and fuels economic growth

By Douglas Petersen  |    May 18, 2023
May is World Trade Month — an opportunity to remind the Biden Administration of the importance of international trade. America’s biopharmaceutical industry, and the hundreds of thousands of Americans...   Read More

ICYMI: PhRMA CMO Dr. Michael Ybarra speaks with Dr. Fabian Sandoval about clinical trial diversity

By Michael Ybarra  |    May 16, 2023
Enhancing clinical trial diversity is a challenge, but with a multi-faceted, community-centered approach, we can help underrepresented patients be more involved in the research and development of...   Read More

3 things about the PhRMA Foundation

By Lori Reilly  |    May 15, 2023
To achieve a healthier world where all people have access to life-changing medicines, we must support researchers working to advance biopharmaceutical innovation and value-driven health care. This is...   Read More

Mental Health Awareness Month: Fighting the growing mental health crisis and supporting innovation

By Andrew Powaleny  |    May 11, 2023
America is currently facing a mental health crisis — one that is impacting families and individuals in every community, with the COVID-19 pandemic only exacerbating these trends. Mental Health...   Read More

Setting the record straight on the Bayh-Dole Act and March-in

By Megan Van Etten  |    May 10, 2023
The National Institutes of Health (NIH) recently made the right decision to uphold the Bayh-Dole Act and not seize patent rights on an innovative medicine by exploiting part of the law known as the...   Read More

Insulin: Key Facts on Access & Affordability

By Sarah Ryan  |    May 10, 2023
Today, the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) will examine the cost of insulin and how to make this lifesaving medicine more affordable for patients. The nation’s...   Read More

4 key facts on medicine prices and spending

By Sarah Ryan  |    May 9, 2023
This week, policymakers on Capitol Hill will continue to discuss the cost of lifesaving medicines and how to make them more affordable for Americans. It’s an important discussion that the...   Read More

Support for continued progress is critical for pediatric drug development

By Abigail Lore  |    May 8, 2023
Researching and developing new medicines for children is a priority for the biopharmaceutical industry. Despite the scientific complexity and challenges inherent to developing treatments for our...   Read More

A win for Indiana patients: “Sharing the savings” legislation now law

By Reid Porter  |    May 8, 2023
Indiana just joined West Virginia and Arkansas in delivering an important win for Hoosiers who are struggling to afford their medicines. This week, Governor Holcomb signed into law Senate Bill 8...   Read More

4 Things to know about PhRMA’s new 50-state poll

By Mark Keida  |    May 4, 2023
When it comes to health care, Americans are concerned about innovation and affordability.   Read More

New resource underscores the importance of small molecule medicines

By Lindsey Seidlitz  |    May 4, 2023
A small molecule medicine is what most people think of when they imagine a medicine. These medicines typically come in the form of a tablet or capsule and are usually taken by mouth. These medicines...   Read More

New PhRMA ad campaign sheds light on PBM abuses

By Robert Zirkelbach  |    May 1, 2023
The Pharmaceutical Research and Manufacturers of America (PhRMA) today launched a new ad campaign that continues to shed light on the role of pharmacy benefit managers (PBMs) in driving up health...   Read More

Americans want state policymakers to lower out-of-pocket costs

By Reid Porter  |    May 1, 2023
Too many Americans are struggling to access and afford their health care. While policy debates about how to address these issues can seem never ending, American adults largely agree on what state...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates